In accordance with the immunomodulatory role of A2AR in TME, the A2AR agonist polydeoxyribonucleotide exhibited anti-inflammatory effects in an ischemic colitis rat model, suppressing the expression of pro-inflammatory cytokines and increasing levels of A2AR and VEGF. The gene discussed is ADORA2A; the disease is ischemic colitis.